Payment overview · 2025
General Payments
$32.40
2 reported records · 2 companies
Healthcare provider profile · identity verified
Kim D Colter, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · WASHINGTON, MO · NPI 1336112846
Verified facts
What the public records show
CMS Open Payments records show Kim D Colter, M.D. received $32.40 in general payments during 2025 across 2 reported records.
Edwards Lifesciences Corporation accounted for 50.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $16.28 | 50.2% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $16.12 | 49.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.40 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Normalized: edwards sapien 3 ultra transcatheter heart valve |
Device | Edwards Lifesciences Corporation | $16.28 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $16.12 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 820 | 125 |
| Eliquis | Apixaban | 672 | 74 |
| Potassium Chloride | Potassium Chloride | 670 | 120 |
| Levothyroxine Sodium | Levothyroxine Sodium | 664 | 73 |
| Furosemide | Furosemide | 607 | 108 |
| Gabapentin | Gabapentin | 502 | 72 |
| Amlodipine Besylate | Amlodipine Besylate | 443 | 81 |
| Lisinopril | Lisinopril | 366 | 67 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 363 | 62 |
| Metoprolol Tartrate | Metoprolol Tartrate | 335 | 65 |
| Sertraline Hcl | Sertraline Hcl | 310 | 47 |
| Mirtazapine | Mirtazapine | 307 | 67 |
| Metformin Hcl | Metformin Hcl | 286 | 32 |
| Omeprazole | Omeprazole | 278 | 50 |
| Quetiapine Fumarate | Quetiapine Fumarate | 261 | 25 |
| Divalproex Sodium | Divalproex Sodium | 254 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 229 | 40 |
| Losartan Potassium | Losartan Potassium | 227 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 223 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 215 | 27 |
| Famotidine | Famotidine | 212 | 22 |
| Tamsulosin Hcl | Tamsulosin Hcl | 211 | 40 |
| Olanzapine | Olanzapine | 210 | 31 |
| Trazodone Hcl | Trazodone Hcl | 210 | 37 |
| Donepezil Hcl | Donepezil Hcl | 209 | 35 |
| Carvedilol | Carvedilol | 205 | 43 |
| Xarelto | Rivaroxaban | 190 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 189 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 184 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 173 | 20 |
| Trulicity | Dulaglutide | 172 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 169 | 30 |
| Celecoxib | Celecoxib | 163 | 22 |
| Levetiracetam | Levetiracetam | 161 | 22 |
| Buspirone Hcl | Buspirone Hcl | 152 | 20 |
| Jardiance | Empagliflozin | 152 | 21 |
| Bumetanide | Bumetanide | 140 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 133 | 21 |
| Memantine Hcl | Memantine Hcl | 133 | 24 |
| Spironolactone | Spironolactone | 116 | 25 |
| Propranolol Hcl | Propranolol Hcl | 110 | suppressed |
| Myrbetriq | Mirabegron | 109 | 12 |
| Alendronate Sodium | Alendronate Sodium | 104 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 101 | 17 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 99 | 14 |
| Nystatin | Nystatin | 93 | 32 |
| Tramadol Hcl | Tramadol Hcl | 93 | 23 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 92 | 11 |
| Allopurinol | Allopurinol | 91 | 17 |
| Amiodarone Hcl | Amiodarone Hcl | 87 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 87 | 26 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 87 | 20 |
| Benztropine Mesylate | Benztropine Mesylate | 84 | suppressed |
| Baclofen | Baclofen | 83 | 14 |
| Nystop | Nystatin | 79 | 32 |
| Pravastatin Sodium | Pravastatin Sodium | 79 | 14 |
| Simvastatin | Simvastatin | 78 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 77 | 11 |
| Aripiprazole | Aripiprazole | 75 | suppressed |
| Haloperidol | Haloperidol | 71 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 71 | 17 |
| Lorazepam | Lorazepam | 70 | 22 |
| Lithium Carbonate | Lithium Carbonate | 69 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 65 | 14 |
| Januvia | Sitagliptin Phosphate | 65 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 65 | 12 |
| Finasteride | Finasteride | 62 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 61 | 15 |
| Prednisone | Prednisone | 59 | 18 |
| Albuterol Sulfate | Albuterol Sulfate | 58 | 29 |
| Pregabalin | Pregabalin | 58 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 57 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 57 | 21 |
| Ondansetron Odt | Ondansetron | 55 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 53 | 13 |
| Lamotrigine | Lamotrigine | 52 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 51 | 32 |
| Fentanyl | Fentanyl | 51 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 51 | 13 |
| Latanoprost | Latanoprost | 51 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 51 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 50 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 49 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 48 | 24 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 46 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 33 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 43 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 43 | suppressed |
| Enulose | Lactulose | 41 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 41 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 25 |
| Topiramate | Topiramate | 40 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 40 | suppressed |
| Meloxicam | Meloxicam | 39 | suppressed |
| Cephalexin | Cephalexin | 38 | 20 |
| Glipizide | Glipizide | 37 | suppressed |
| Levofloxacin | Levofloxacin | 37 | 22 |
| Clonidine Hcl | Clonidine Hcl | 36 | suppressed |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 35 | suppressed |
| Digoxin | Digoxin | 35 | suppressed |
| Ozempic | Semaglutide | 35 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 35 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | suppressed |
| Cefdinir | Cefdinir | 34 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 34 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 14 |
| Clonazepam | Clonazepam | 32 | suppressed |
| Glimepiride | Glimepiride | 31 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 31 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | 22 |
| Dicyclomine Hcl | Dicyclomine Hcl | 29 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 29 | suppressed |
| Risperidone | Risperidone | 29 | suppressed |
| Alprazolam | Alprazolam | 28 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 28 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 28 | suppressed |
| Minoxidil | Minoxidil | 28 | suppressed |
| Novolog Flexpen | Insulin Aspart | 28 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 28 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Klayesta | Nystatin | 27 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Ibuprofen | Ibuprofen | 25 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 25 | suppressed |
| Verapamil Er | Verapamil Hcl | 25 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 23 | suppressed |
| Olanzapine Odt | Olanzapine | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Clozapine | Clozapine | 22 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 22 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 22 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 21 | 19 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 21 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 17 |
| Prazosin Hcl | Prazosin Hcl | 20 | suppressed |
| Restasis | Cyclosporine | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 19 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Lumigan | Bimatoprost | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 19 | suppressed |
| Tresiba | Insulin Degludec | 19 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 18 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 18 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 16 | suppressed |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Letrozole | Letrozole | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 15 | suppressed |
| Nyamyc | Nystatin | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Sotalol | Sotalol Hcl | 15 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 15 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Atenolol | Atenolol | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Budesonide | Budesonide | 12 | suppressed |
| Exemestane | Exemestane | 12 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 12 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 11 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.40 · 2 records | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error